Jobling M F, Stewart L R, White A R, McLean C, Friedhuber A, Maher F, Beyreuther K, Masters C L, Barrow C J, Collins S J, Cappai R
Department of Pathology and School of Chemistry, University of Melbourne, Parkville, Victoria, Australia.
J Neurochem. 1999 Oct;73(4):1557-65. doi: 10.1046/j.1471-4159.1999.0731557.x.
The neurodegeneration seen in spongiform encephalopathies is believed to be mediated by protease-resistant forms of the prion protein (PrP). A peptide encompassing residues 106-126 of human PrP has been shown to be neurotoxic in vitro. The neurotoxicity of PrP106-126 appears to be dependent upon its adoption of an aggregated fibril structure. To examine the role of the hydrophobic core, AGAAAAGA, on PrP106-126 toxicity, we performed structure-activity analyses by substituting two or more hydrophobic residues for the hydrophilic serine residue to decrease its hydrophobicity. A peptide with a deleted alanine was also synthesized. We found all the peptides except the deletion mutant were no longer toxic on mouse cerebellar neuronal cultures. Circular dichroism analysis showed that the nontoxic PrP peptides had a marked decrease in beta-sheet structure. In addition, the mutants had alterations in aggregability as measured by turbidity, Congo red binding, and fibril staining using electron microscopy. These data show that the hydrophobic core sequence is important for PrP106-126 toxicity probably by influencing its assembly into a neurotoxic structure. The hydrophobic sequence may similarly affect aggregation and toxicity observed in prion diseases.
在海绵状脑病中观察到的神经退行性变被认为是由抗蛋白酶形式的朊病毒蛋白(PrP)介导的。包含人PrP 106 - 126位残基的肽段已被证明在体外具有神经毒性。PrP106 - 126的神经毒性似乎取决于其聚集的纤维结构。为了研究疏水核心序列AGAAAAGA对PrP106 - 126毒性的作用,我们通过用两个或更多疏水残基取代亲水性丝氨酸残基以降低其疏水性来进行结构 - 活性分析。还合成了一个缺失丙氨酸的肽段。我们发现除缺失突变体之外的所有肽段对小鼠小脑神经元培养物不再具有毒性。圆二色性分析表明,无毒的PrP肽段的β - 折叠结构显著减少。此外,通过浊度、刚果红结合以及使用电子显微镜的纤维染色测量,突变体在聚集性方面发生了改变。这些数据表明,疏水核心序列可能通过影响其组装成神经毒性结构而对PrP106 - 126的毒性很重要。疏水序列可能同样影响在朊病毒疾病中观察到的聚集和毒性。